Hospira GemStar Infusion System Recalled by FDA for Battery Malfunction

An FDA Class 1 recall has been issued for Hospira’s GemStar Infusion System, a device for use in intravenous, arterial, subcutaneous, short-term infusion and parenteral administration of general IV fluids and medications, according to the American Society of Anesthesiologists.

Advertisement

FDA recalls Hospira GemStar Infusion SystemThe problem stems from the lithium battery voltage, which can drop below 2.4 volts and interrupt the device’s operations. The battery malfunction can also erase infusion settings and event history logs.

All lithium batteries older than three years should be replaced, according to the release. For more information, check with the FDA’s MedWatch Safety Information and Adverse Event Reporting Program.

More Articles on Anesthesia:
Georgia-based Gwinnett Anesthesia Service Acquired by MEDNAX
Study: Neuraxial Anesthesia Brings Better Outcomes for Knee, Hip Arthroplasty
ASA Seeks Further Hardship Exemptions for Anesthesiologists

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.